Human Milk Oligosaccharides (HMO) Market - Forecast(2021 - 2026)

Report Code: FBR 0264 Report Format: PDF + Excel (Delivery in 48 Hrs)

Human Milk Oligosaccharides Market Overview

Human Milk Oligosaccharides (HMO) Market size was estimated at $72.6 Million in 2020, projected to grow at a CAGR of 5.9% during the forecast period 2021-2026. Human Milk Oligosaccharides industry has witnessed huge demand owing to the rising customer concerns about gut health and an increase in the use of food supplements or dietary supplements. Human Milk Oligosaccharides are prebiotics that help preserve gut health in humans. They promote bacterial growth in the gut, especially in the bifidobacteria genus, that helps to boost metabolic activity. The antimicrobial and prebiotic properties of the product allows it to be used in a wide range of foods, including pharmaceutical and medicinal foods, as well as infant formulas. HMOs are sugars, the third most abundant solid after lactose and fats in human breast milk. It improves and enhances infant health by supporting immune, cognitive development, digestion and also has the potential that benefits adults. Some of the nutrition effects of HMOs found in human milk can be mimicked by commercially manufactured HMOs. HMO that is made by fermentation helps infant formula manufacturers to produce formula that is similar to human milk than ever before, allowing formula-fed babies to reap the benefits of these vital components of breast milk. Human milk oligosaccharides have many primary roles, including infection prevention, prebiotic effects and to supply of sialic acid for brain growth. When compared to human milk, infant formulas made from bovine milk have a lower concentration of oligosaccharides. Since HMOs are beneficial to the microbiome and immunity, key players are researching and developing new techniques, such as extracting HMO from cow milk, using costly techniques or even using microbes to generate them.

Report Coverage

The report: “Human Milk Oligosaccharides Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Human Milk Oligosaccharides Market.
By Product: Lacto-N-neotetraose, Lacto-N-tetraose , 2'-Fucosyllactose, 3'-Fucosyllactose, 3'-Sialyllactose, 6'-Sialyllactose. 
By Application: Food Supplements, Functional food & Beverages, Infant Formula, and Others. 
By Type: Acidic, Neutral.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Spain, Italy, Russia and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia & New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina and Rest of South America), and Rest of the World (Middle East and Africa).

Key Takeaways

  • In 2020, North America led the Human Milk Oligosaccharides Market owing to the presence of key market players and prominent baby food manufacturers in this region. 
  • Growing consumer concerns on gut health, as well as increasing consumption of dietary supplements, are expected to propel the Human Milk Oligosaccharides Market.
  • The cost of production of Human Milk Oligosaccharides via chemical and enzymatic synthesis method along with low availability of raw material are projected to restrain the market growth. 
  • Furthermore, lack of high-end production technology, high R&D costs, in addition to rigorous regulations is likely limit the growth of the Human Milk Oligosaccharide industry.

Human Milk Oligosaccharides Market: Market Share (%) by Region, 2020
Human Milk Oligosaccharides Market
For More Details on This Report - Request for Sample

Human Milk Oligosaccharides Market Segment Analysis – By Product

Based on Product, Human Milk Oligosaccharides market is segmented into Lacto-N-neotetraose, Lacto-N-tetraose, 2'-Fucosyllactose, 3'-Fucosyllactose, 3'-Sialyllactose, 6'-Sialyllactose. Lacto-N-neotetraose accounted for the largest revenue market share in 2020 owing the rising growth of beneficial bifidobacteria and downfall in the growth of pathogenic bacteria that ultimately attracts the manufacturers of food and beverages as a result of the growing awareness that human milk oligosaccharides markets are showing amongst customers. 2'-Fucosyllactose is poised to grow with the fastest CAGR of 6.3% in the forecast period 2021-2026 as dietary supplement manufacturers shift to 2'-Fucosyllactose, since it is capable of altering gut microbiota composition and behavior from formula-powered infants receiving additional feeding, and its contribution to healthy digestion.

Human Milk Oligosaccharides Market Segment Analysis – By Application:

Based on Application, Human Milk Oligosaccharides market is segmented into Functional food & Beverages, Infant Formula, Food Supplements, and Others. Infant Formula segment is accounted for the largest revenue market share in 2020 owing to HMOs' impacts, such as brain growth, infection prevention, memory enhancement, prenatal effects, and gut health maintenance. Functional foods and Beverages predicted to grow with the fastest CAGR of 6.5% in the forecast period 2021-2026 owing to the numerous health benefits offered by HMO, its use in functional food and beverage formulations is projected to increase dramatically over the forecast period, driving product demand. The use of HMOs in dietary supplements has many benefits, including improved immune, bacterial, and viral protection, improved digestion by maintaining gut health, and support for brain function.

Human Milk Oligosaccharides Market Segment Analysis – By Geography:

Based on Geography, North America Human Milk Oligosaccharides Market accounted for the 39% revenue share in 2020. This is majorly attributed to the technological advancement along with presence of key market players in this region. Growing consumer consciousness in the area, one of the main factors helping the business in the country to expand further with numerous product launches is the health benefits of HMO. In 2016 for instance, Jennewein Biotechnologie GmbH developed 2'-fucosylactose as a food grade quality commodity for the first time to satisfy the requirements of the US market for formula for children. HMO market is expected to expand in the region with the growing incorporation of HMO into the prebiotics as it helped to establish commensal bacteria and increased demand for functional foods and beverages and dietary supplements for improving health and digestions. Asia-Pacific market is poised to grow with the fastest CAGR in the forecast period 2021-2026 owing its increase in aging population. According to the World Health Organization, the global population is estimated to grow by around 1 billion in the next ten years, reaching 9.5 billion by 2050. The demand for infant nutrition products is expected to rise as the world's population continues to expand. Owing to the large number of infants in China and other Asia Pacific countries, demand for infant formula is extremely strong.

Human Milk Oligosaccharides Market Segment Analysis-Drivers

Demand for HMO in Infant Formula

Owing to the concerns about child malnutrition and mortality around the world, demand for HMO in infant formula is accelerating the market growth. Human milk oligosaccharides (HMO) have prebiotic properties, the potential to improve memory and brain growth, and a high nutritional value, all of which drive consumer demand (HMO). The breast milk's ability to protect babies from infection and protect them against allergic reactions would influence the market size. It appears that human milk provides long-term defense against obesity, hypertension, auto-immune, diabetes and heart diseases to human beings. The compound also prevents the attachment of microbes to gut, pathogens which organic acids, and helps to reduce inflammation and thereby drive business trends. The substance contributes to gut health by increasing the synthesis of short-chain fatty acids – a primary energy source for enterocytes and a principal molecule for the preservation of intestinal health.

Human Milk Oligosaccharides Market Segment Analysis-Challenges

High Cost of Production:

The third largest portion of human milk is human oligosaccharides that cannot be synthesized directly by means of human milk as the donor group is in limited supply. Currently, manufacturers are using chemical and enzyme synthesis for the production of human milk oligosaccharides. These methods require high resources and money, but the final output product is relatively small. For example, expensive substrates such as glycosyl transferases require enzyme synthesis and this is one of the main factors attributable to the high pricing of human milk oligosaccharides. Prebiotics in infant formula, such as fructooligosaccharides and galactooligosaccharides, are used to inhibit the development of pathogenic Escherichia coli. Consumption of these has been shown to improve the health of infants' gastrointestinal tracts by promoting the development of specific microorganisms in the intestinal microflora. Owing to their low cost and wide availability, these are being used as a replacement for human milk oligosaccharides by infant formula manufacturers. As a result, these functionally equivalent alternatives to human milk oligosaccharides are severely limiting the overall market's expansion.

Human Milk Oligosaccharides Market Segment Landscape:

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Human Milk Oligosaccharides Market. Human Milk Oligosaccharides Market top 10 companies are ZuChem, Inc., Elicityl SA, Jennewein Biotechnologie GmbH, Inbiose, Glycosyn LLC, Medolac Laboratories, Glycom A/S, Nestle Nutrition, DuPont Nutrition, BASF SE. 

Acquisitions/Product Launches:

  • In May 2019, BASF SE and Glycosyn LLC has signed an agreement to develop and commercialize HMO for use in dietary supplements, functional nutrition, and medicinal food. BASF SE expands its offering of the most abundant HMO, 2'-Fucosyllactose (2'-FL) labelled PREBILACTM, to emerging markets as part of the partnership and under the exclusive license.

Related Reports:

For more Food and Beverage Market reports, please click here
1. Human Milk Oligosaccharides Market - Overview
    1.1 Definitions and Scope
2. Human Milk Oligosaccharides Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product
    2.3 Key trends by Application
    2.4 Key trends by Form
    2.5 Key trends by Type
    2.6 Key trends by Geography
3. Human Milk Oligosaccharides Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split - Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis – Average Selling Price
4. Human Milk Oligosaccharides Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Human Milk Oligosaccharides Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Human Milk Oligosaccharides Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Human Milk Oligosaccharides Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Human Milk Oligosaccharides Market – By Product (Market Size –$Million/$Billion)
    8.1 Lacto-N-neotetraose
    8.2 Lacto-N-tetraose
    8.3 2'-Fucosyllactose
    8.4 3'-Fucosyllactose
    8.5 3'-Sialyllactose
    8.6 6'-Sialyllactose
9. Human Milk Oligosaccharides Market – By Application (Market Size –$Million/$Billion)
    9.1 Food Supplements
    9.2 Functional food & Beverages
    9.3 Infant Formula
    9.4 Others
10. Human Milk Oligosaccharides Market – By Type(Market Size –$Million/$Billion)
    10.1 Acidic
    10.2 Neutral
11. Human Milk Oligosaccharides Market - By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Human Milk Oligosaccharides Market - Entropy
13. Human Milk Oligosaccharides Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Human Milk Oligosaccharides Market – Key Company List by Country Premium Premium
15. Human Milk Oligosaccharides Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables
Table 1 Human Milk Oligosaccharides (HMO) Market Overview 2019-2024
Table 2 Human Milk Oligosaccharides (HMO) Market Leader Analysis 2018-2019 (US$)
Table 3 Human Milk Oligosaccharides (HMO) Market Product Analysis 2018-2019 (US$)
Table 4 Human Milk Oligosaccharides (HMO) Market End User Analysis 2018-2019 (US$)
Table 5 Human Milk Oligosaccharides (HMO) Market Patent Analysis 2013-2018* (US$)
Table 6 Human Milk Oligosaccharides (HMO) Market Financial Analysis 2018-2019 (US$)
Table 7 Human Milk Oligosaccharides (HMO) Market Driver Analysis 2018-2019 (US$)
Table 8 Human Milk Oligosaccharides (HMO) Market Challenges Analysis 2018-2019 (US$)
Table 9 Human Milk Oligosaccharides (HMO) Market Constraint Analysis 2018-2019 (US$)
Table 10 Human Milk Oligosaccharides (HMO) Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11 Human Milk Oligosaccharides (HMO) Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12 Human Milk Oligosaccharides (HMO) Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13 Human Milk Oligosaccharides (HMO) Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14 Human Milk Oligosaccharides (HMO) Market Degree of Competition Analysis 2018-2019 (US$)
Table 15 Human Milk Oligosaccharides (HMO) Market Value Chain Analysis 2018-2019 (US$)
Table 16 Human Milk Oligosaccharides (HMO) Market Pricing Analysis 2019-2024 (US$)
Table 17 Human Milk Oligosaccharides (HMO) Market Opportunities Analysis 2019-2024 (US$)
Table 18 Human Milk Oligosaccharides (HMO) Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19 Human Milk Oligosaccharides (HMO) Market Supplier Analysis 2018-2019 (US$)
Table 20 Human Milk Oligosaccharides (HMO) Market Distributor Analysis 2018-2019 (US$)
Table 21 Human Milk Oligosaccharides (HMO) Market Trend Analysis 2018-2019 (US$)
Table 22 Human Milk Oligosaccharides (HMO) Market Size 2018 (US$)
Table 23 Human Milk Oligosaccharides (HMO) Market Forecast Analysis 2019-2024 (US$)
Table 24 Human Milk Oligosaccharides (HMO) Market Sales Forecast Analysis 2019-2024 (Units)
Table 25 Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 26 Human Milk Oligosaccharides (HMO) Market By Type, Revenue & Volume, By Introduction, 2019-2024 ($)
Table 27 Human Milk Oligosaccharides (HMO) Market By Type, Revenue & Volume, By Neutral, 2019-2024 ($)
Table 28 Human Milk Oligosaccharides (HMO) Market By Type, Revenue & Volume, By Acidic, 2019-2024 ($)
Table 29 Human Milk Oligosaccharides (HMO) Market By Type, Revenue & Volume, By Others, 2019-2024 ($)
Table 30 Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 31 Human Milk Oligosaccharides (HMO) Market By Product, Revenue & Volume, By Introduction, 2019-2024 ($)
Table 32 Human Milk Oligosaccharides (HMO) Market By Product, Revenue & Volume, By Lacto-N-neotetraose (LnnT), 2019-2024 ($)
Table 33 Human Milk Oligosaccharides (HMO) Market By Product, Revenue & Volume, By Lacto-N-tetraose (LNT), 2019-2024 ($)
Table 34 Human Milk Oligosaccharides (HMO) Market By Product, Revenue & Volume, By 2'-Fucosyllactose (2'FL), 2019-2024 ($)
Table 35 Human Milk Oligosaccharides (HMO) Market By Product, Revenue & Volume, By 3'-Fucosyllactose (3'FL), 2019-2024 ($)
Table 36 Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 37 Human Milk Oligosaccharides (HMO) Market By Application, Revenue & Volume, By Introduction, 2019-2024 ($)
Table 38 Human Milk Oligosaccharides (HMO) Market By Application, Revenue & Volume, By Food & beverages, 2019-2024 ($)
Table 39 Human Milk Oligosaccharides (HMO) Market By Application, Revenue & Volume, By Food supplements, 2019-2024 ($)
Table 40 Human Milk Oligosaccharides (HMO) Market By Application, Revenue & Volume, By Infant formulas, 2019-2024 ($)
Table 41 Human Milk Oligosaccharides (HMO) Market By Application, Revenue & Volume, By Others, 2019-2024 ($)
Table 42 North America Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 43 North America Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 44 North America Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 45 South america Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 46 South america Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 47 South america Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 48 Europe Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 49 Europe Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 50 Europe Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 51 APAC Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 52 APAC Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 53 APAC Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 54 Middle East & Africa Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 55 Middle East & Africa Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 56 Middle East & Africa Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 57 Russia Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 58 Russia Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 59 Russia Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 60 Israel Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 61 Israel Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 62 Israel Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 63 Top Companies 2018 (US$)Human Milk Oligosaccharides (HMO) Market, Revenue & Volume
Table 64 Product Launch 2018-2019Human Milk Oligosaccharides (HMO) Market, Revenue & Volume
Table 65 Mergers & Acquistions 2018-2019Human Milk Oligosaccharides (HMO) Market, Revenue & Volume

List of Figures
Figure 1 Overview of Human Milk Oligosaccharides (HMO) Market 2019-2024
Figure 2 Market Share Analysis for Human Milk Oligosaccharides (HMO) Market 2018 (US$)
Figure 3 Product Comparison in Human Milk Oligosaccharides (HMO) Market 2018-2019 (US$)
Figure 4 End User Profile for Human Milk Oligosaccharides (HMO) Market 2018-2019 (US$)
Figure 5 Patent Application and Grant in Human Milk Oligosaccharides (HMO) Market 2013-2018* (US$)
Figure 6 Top 5 Companies Financial Analysis in Human Milk Oligosaccharides (HMO) Market 2018-2019 (US$)
Figure 7 Market Entry Strategy in Human Milk Oligosaccharides (HMO) Market 2018-2019
Figure 8 Ecosystem Analysis in Human Milk Oligosaccharides (HMO) Market 2018
Figure 9 Average Selling Price in Human Milk Oligosaccharides (HMO) Market 2019-2024
Figure 10 Top Opportunites in Human Milk Oligosaccharides (HMO) Market 2018-2019
Figure 11 Market Life Cycle Analysis in Human Milk Oligosaccharides (HMO) Market
Figure 12 GlobalBy TypeHuman Milk Oligosaccharides (HMO) Market Revenue, 2019-2024 ($)
Figure 13 GlobalBy ProductHuman Milk Oligosaccharides (HMO) Market Revenue, 2019-2024 ($)
Figure 14 GlobalBy ApplicationHuman Milk Oligosaccharides (HMO) Market Revenue, 2019-2024 ($)
Figure 15 Global Human Milk Oligosaccharides (HMO) Market - By Geography
Figure 16 Global Human Milk Oligosaccharides (HMO) Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 17 Global Human Milk Oligosaccharides (HMO) Market CAGR, By Geography, 2019-2024 (%)
Figure 18 North America Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 19 US Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 20 US GDP and Population, 2018-2019 ($)
Figure 21 US GDP – Composition of 2018, By Sector of Origin
Figure 22 US Export and Import Value & Volume, 2018-2019 ($)
Figure 23 Canada Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 24 Canada GDP and Population, 2018-2019 ($)
Figure 25 Canada GDP – Composition of 2018, By Sector of Origin
Figure 26 Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 27 Mexico Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 28 Mexico GDP and Population, 2018-2019 ($)
Figure 29 Mexico GDP – Composition of 2018, By Sector of Origin
Figure 30 Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 31 South America Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 32 Brazil Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 33 Brazil GDP and Population, 2018-2019 ($)
Figure 34 Brazil GDP – Composition of 2018, By Sector of Origin
Figure 35 Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 36 Venezuela Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 37 Venezuela GDP and Population, 2018-2019 ($)
Figure 38 Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 39 Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 40 Argentina Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 41 Argentina GDP and Population, 2018-2019 ($)
Figure 42 Argentina GDP – Composition of 2018, By Sector of Origin
Figure 43 Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 44 Ecuador Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 45 Ecuador GDP and Population, 2018-2019 ($)
Figure 46 Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 47 Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 48 Peru Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 49 Peru GDP and Population, 2018-2019 ($)
Figure 50 Peru GDP – Composition of 2018, By Sector of Origin
Figure 51 Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 52 Colombia Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 53 Colombia GDP and Population, 2018-2019 ($)
Figure 54 Colombia GDP – Composition of 2018, By Sector of Origin
Figure 55 Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 56 Costa Rica Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 57 Costa Rica GDP and Population, 2018-2019 ($)
Figure 58 Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 59 Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 60 Europe Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 61 U.K Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 62 U.K GDP and Population, 2018-2019 ($)
Figure 63 U.K GDP – Composition of 2018, By Sector of Origin
Figure 64 U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 65 Germany Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 66 Germany GDP and Population, 2018-2019 ($)
Figure 67 Germany GDP – Composition of 2018, By Sector of Origin
Figure 68 Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 69 Italy Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 70 Italy GDP and Population, 2018-2019 ($)
Figure 71 Italy GDP – Composition of 2018, By Sector of Origin
Figure 72 Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 73 France Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 74 France GDP and Population, 2018-2019 ($)
Figure 75 France GDP – Composition of 2018, By Sector of Origin
Figure 76 France Export and Import Value & Volume, 2018-2019 ($)
Figure 77 Netherlands Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 78 Netherlands GDP and Population, 2018-2019 ($)
Figure 79 Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 80 Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 81 Belgium Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 82 Belgium GDP and Population, 2018-2019 ($)
Figure 83 Belgium GDP – Composition of 2018, By Sector of Origin
Figure 84 Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 85 Spain Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 86 Spain GDP and Population, 2018-2019 ($)
Figure 87 Spain GDP – Composition of 2018, By Sector of Origin
Figure 88 Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 89 Denmark Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 90 Denmark GDP and Population, 2018-2019 ($)
Figure 91 Denmark GDP – Composition of 2018, By Sector of Origin
Figure 92 Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 93 APAC Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 94 China Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024
Figure 95 China GDP and Population, 2018-2019 ($)
Figure 96 China GDP – Composition of 2018, By Sector of Origin
Figure 97 China Export and Import Value & Volume, 2018-2019 ($)Human Milk Oligosaccharides (HMO) Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 98 Australia Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 99 Australia GDP and Population, 2018-2019 ($)
Figure 100 Australia GDP – Composition of 2018, By Sector of Origin
Figure 101 Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 102 South Korea Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 103 South Korea GDP and Population, 2018-2019 ($)
Figure 104 South Korea GDP – Composition of 2018, By Sector of Origin
Figure 105 South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 106 India Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 107 India GDP and Population, 2018-2019 ($)
Figure 108 India GDP – Composition of 2018, By Sector of Origin
Figure 109 India Export and Import Value & Volume, 2018-2019 ($)
Figure 110 Taiwan Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 111 Taiwan GDP and Population, 2018-2019 ($)
Figure 112 Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 113 Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 114 Malaysia Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 115 Malaysia GDP and Population, 2018-2019 ($)
Figure 116 Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 117 Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 118 Hong Kong Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 119 Hong Kong GDP and Population, 2018-2019 ($)
Figure 120 Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 121 Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 122 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 123 Russia Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 124 Russia GDP and Population, 2018-2019 ($)
Figure 125 Russia GDP – Composition of 2018, By Sector of Origin
Figure 126 Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 127 Israel Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 128 Israel GDP and Population, 2018-2019 ($)
Figure 129 Israel GDP – Composition of 2018, By Sector of Origin
Figure 130 Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 131 Entropy Share, By Strategies, 2018-2019* (%)Human Milk Oligosaccharides (HMO) Market
Figure 132 Developments, 2018-2019*Human Milk Oligosaccharides (HMO) Market
Figure 133 Company 1 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 134 Company 1 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 135 Company 1 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 136 Company 2 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 137 Company 2 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 138 Company 2 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 139 Company 3 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 140 Company 3 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 141 Company 3 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 142 Company 4 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 143 Company 4 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 144 Company 4 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 145 Company 5 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 146 Company 5 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 147 Company 5 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 148 Company 6 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 149 Company 6 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 150 Company 6 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 151 Company 7 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 152 Company 7 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 153 Company 7 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 154 Company 8 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 155 Company 8 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 156 Company 8 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 157 Company 9 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 158 Company 9 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 159 Company 9 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 160 Company 10 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 161 Company 10 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 162 Company 10 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 163 Company 11 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 164 Company 11 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 165 Company 11 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 166 Company 12 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 167 Company 12 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 168 Company 12 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 169 Company 13 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 170 Company 13 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 171 Company 13 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 172 Company 14 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 173 Company 14 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 174 Company 14 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 175 Company 15 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 176 Company 15 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 177 Company 15 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)